Back to Search
ALBERT SANDLER, D.M.D.
D.M.D.
General Practice Dentistry
NPI: 1215045273Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
16513(MA)
Research & Publications (20)
Advanced non-small-cell lung cancer: new data, therapy choices, and challenging decisions.
PMID 16773846·Oncology (Williston Park)·2006
6-review
Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer.
PMID 15217970·Clin Cancer Res·2004
6-review
A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy.
PMID 15161679·Clin Cancer Res·2004
3-trial
Clinical experience with the HER1/EGFR tyrosine kinase inhibitor erlotinib.
PMID 14682119·Oncology (Williston Park)·2003
6-review
State-of-the-art treatment for advanced non-small-cell lung cancer.
PMID 14723002·Oncology (Williston Park)·2003
6-review
Irinotecan plus cisplatin in small-cell lung cancer.
PMID 12375800·Oncology (Williston Park)·2002
6-review
Irinotecan in small-cell lung cancer: current data and the status of ongoing trials.
PMID 14659039·Clin Lung Cancer·2002
8-other
Irinotecan in small-cell lung cancer: the US experience.
PMID 11221015·Oncology (Williston Park)·2001
6-review
Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction.
PMID 11061612·Ann Oncol·2000
3-trial
Angiogenesis in the treatment of non-small cell lung cancer.
PMID 19349490·Proc Am Thorac Soc·2009
6-review
Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer.
PMID 19362948·Clin Lung Cancer·2009
6-review
A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC).
PMID 19404213·J Thorac Oncol·2009
3-trial
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.
PMID 19404214·J Thorac Oncol·2009
3-trial
The right to nutrition and hydration: a need for vigilance.
PMID 19489668·Intellect Dev Disabil·2009
8-other
Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer.
PMID 19671872·Clin Cancer Res·2009
6-review
Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
PMID 19597027·J Clin Oncol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 369 MERRIMACK ST, SUITE G
METHUEN, MA 01844 - Phone
- (978) 683-3343
Quick Facts
- NPI
- 1215045273
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile